Advancing Knowledge. Enhancing Care.
Advancing Knowledge. Enhancing Care.

Psoriasis News

the latest news from ipc, industry and others

As more biosimilars become available around the world, it is important for dermatologists and others who provide care to patients with psoriasis to have a keen understanding of these treatment options and to be able to discuss biosimilars' safety and efficacy with patients.

IPC’s 2019 biosimilars initiative focuses on educating healthcare practitioners around the globe on the similarities and differences between reference biologics, biosimilars and biomimics. The resources provided here offer background information on biosimilars, suggest practical guidance on communicating biosimilar benefits to patients, and present real-world clinical scenarios of psoriasis management with biosimilars.

We are pleased to offer the following educational opportunities to health care practitioners around the globe:

  • On-demand webcasts
  • IPC published manuscripts as a result of IPC's Biosimilars Working Group
  • Upcoming educational symposiums
  • Other trusted tools and resources

Explore IPC’s biosimilars resources HERE.

This program is sponsored in part by Samsung Bioepis and Biogen.

Stay informed

Join the email list to receive the latest information on psoriasis meetings, manuscripts and research.

now available

COVID-19 Psoriasis Resource Center

Information from around the world on psoriasis and coronavirus to assist dermatologists and the patients they serve

explore now


We use cookies on this site to enhance your online experience. By continuing to use this site, you agree to accept cookies.